NO20000330L - FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein - Google Patents

FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Info

Publication number
NO20000330L
NO20000330L NO20000330A NO20000330A NO20000330L NO 20000330 L NO20000330 L NO 20000330L NO 20000330 A NO20000330 A NO 20000330A NO 20000330 A NO20000330 A NO 20000330A NO 20000330 L NO20000330 L NO 20000330L
Authority
NO
Norway
Prior art keywords
lipid
protein
articles
procedure
production
Prior art date
Application number
NO20000330A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000330D0 (no
Inventor
Matthias Andersson
Dorota Johansson
Percy Li
Bjoern Norrlind
Bengt Westgren
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO20000330D0 publication Critical patent/NO20000330D0/no
Publication of NO20000330L publication Critical patent/NO20000330L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000330A 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein NO20000330L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702776A SE9702776D0 (sv) 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions
PCT/SE1998/001407 WO1999004761A1 (en) 1997-07-22 1998-07-22 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein

Publications (2)

Publication Number Publication Date
NO20000330D0 NO20000330D0 (no) 2000-01-21
NO20000330L true NO20000330L (no) 2000-03-21

Family

ID=20407807

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000330A NO20000330L (no) 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Country Status (12)

Country Link
EP (1) EP1014947B1 (pt)
JP (1) JP3813439B2 (pt)
AT (1) ATE289806T1 (pt)
AU (1) AU744738B2 (pt)
CA (1) CA2297924C (pt)
DE (1) DE69829191T2 (pt)
ES (1) ES2236919T3 (pt)
NO (1) NO20000330L (pt)
NZ (1) NZ502840A (pt)
PT (1) PT1014947E (pt)
SE (1) SE9702776D0 (pt)
WO (1) WO1999004761A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156781B1 (en) * 1999-02-26 2005-06-08 Chiron Corporation Microemulsions with adsorbed macromolecules and microparticles
AU2596401A (en) * 1999-12-22 2001-07-03 Surgical Sealants, Inc. Methods and compositions for sealing tissue leaks
CA2368502A1 (en) * 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C10 heterosubstituted acetate taxanes as antitumor agents
US6514523B1 (en) * 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
CA2407027C (en) * 2000-04-20 2011-02-15 Rtp Pharma Inc. Improved water-insoluble drug particle process
US6599441B1 (en) * 2000-07-18 2003-07-29 Emerald Biostructures, Inc. Crystallization solutions
US7803400B2 (en) 2002-12-03 2010-09-28 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
CA2507762C (en) 2002-12-03 2013-02-05 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
RU2005130646A (ru) 2003-04-04 2006-01-27 Пфайзер Продактс Инк. (Us) Микрофлюидизированные эмульсии масло в воде и композиции вакцины
WO2006082824A1 (ja) * 2005-02-03 2006-08-10 Nrl Pharma, Inc. マトリックス型腸溶性・徐放性組成物
WO2006109936A1 (en) * 2005-03-28 2006-10-19 Regeron, Inc. Methods for preparing nanoliposome encapsulating proteins and protein-encapsulated nanoliposome
US20070151853A1 (en) * 2005-12-29 2007-07-05 Invitrogen Corporation Compositions and Methods for Improving Resolution of Biomolecules Separated on Polyacrylamide Gels
EP1915986A1 (en) * 2006-10-23 2008-04-30 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Lipid growth factor formulations
CH715456B1 (de) 2007-04-27 2020-04-30 Mibelle Ag Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet.
US8071759B2 (en) 2008-07-18 2011-12-06 Affymetrix, Inc. Water soluble cholesterol derivatives
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
EP3150194A1 (en) 2009-08-31 2017-04-05 NanoCarrier Co., Ltd. Particle composition and medicinal composition comprising same
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
WO2025215934A1 (ja) * 2024-04-09 2025-10-16 コニカミノルタ株式会社 予測装置、予測装置の粒径分布予測方法、および粒径分布予測プログラム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins

Also Published As

Publication number Publication date
NZ502840A (en) 2002-08-28
JP3813439B2 (ja) 2006-08-23
ES2236919T3 (es) 2005-07-16
JP2001510786A (ja) 2001-08-07
EP1014947A1 (en) 2000-07-05
SE9702776D0 (sv) 1997-07-22
DE69829191D1 (de) 2005-04-07
WO1999004761A1 (en) 1999-02-04
AU8371898A (en) 1999-02-16
CA2297924A1 (en) 1999-02-04
EP1014947B1 (en) 2005-03-02
ATE289806T1 (de) 2005-03-15
NO20000330D0 (no) 2000-01-21
DE69829191T2 (de) 2005-07-21
CA2297924C (en) 2007-04-10
PT1014947E (pt) 2005-05-31
AU744738B2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
NO20000330L (no) FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein
AU649973B2 (en) Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present
DE69802005D1 (de) Kombination aus prolaminen und polaren pflanzlichen lipiden, verfahren zu deren herstellung sowie deren verwendungen
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
ZA961898B (en) Novel melatonin-antagonist beta-carboline derivatives and analogues thereof containing naphthalenic structure process for their preparation and their medicinal products
IL82231A0 (en) 1-hydroxy-2-pyridones,process for their preparation,and pharmaceutical compositions which contain them and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
IL83357A (en) Renin-inhibiting peptides, process for their preparation, pharmaceutical compositions containing them, and their use
DK227282A (da) Anti-thrombotikum baseret paa polysaccharider fremgangsmaade til dets fremstilling og farmaceutiske produkter
DE3767998D1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
BR9508034A (pt) Processo e aparelhagem para a preparação de uma unidade comestível que se dissolve rapidamente a referida unidade composição para liberar um ingrediente ativo processo para administração de um ingrediente ativo a um hospedeiro humano e produto provisório para fabricação da unidade comestível
HUT40677A (en) Process for preparing water-soluble platinum compounds and pharmaceutical preparations comprising these compounds as active substance
FI921562A7 (fi) Gem-difosfonihapot, menetelmä niiden valmistamiseksi ja farmaseuttiset koostumukset, jotka sisältävät niitä
AU583255B2 (en) New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions
ZA848141B (en) New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions
AU6551198A (en) Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
DE3768084D1 (de) Rekonstituiertes nahrungsmittel, verfahren und mischer zu seiner herstellung.
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
YU48978B (sh) Postupak za dobijanje preparata koji sadrži trandolapril i verapamil
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
FR2595703B1 (fr) Nouveaux phospholipides, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
HUP0105056A2 (en) Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids, process for their preparation and pharmaceutical compositions containing them
DZ2827A1 (fr) Nouveaux 19-nor stéroïdes 17-halogéneés, procédé et intermédiares de préparation, application commemédicaments et compositions pharmaceutiques les r enfermant.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application